A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT03445559
Collaborator
(none)
58
11
2
58.7
5.3
0.1

Study Details

Study Description

Brief Summary

The primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging imaging. Other aims of this study include to use mixed methods to explore physician influence on guideline-concordant imaging and to determine the cost and cost impact of a physician-focused behavioral intervention to improve guideline-concordant prostate cancer imaging.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Clinical Order Check
  • Behavioral: Academic Detailing
  • Behavioral: Audit and Feedback
N/A

Detailed Description

Almost half of Veterans with localized prostate cancer (the most common non-cutaneous malignancy among US men) receive inappropriate, wasteful imaging. The VHA Blueprint for Excellence prioritizes increasing operational effectiveness. Prior studies seeking to limit inappropriate imaging did not assess barriers and achieved mixed results. The investigators' team has explored the causes of guideline-discordant prostate cancer imaging and found that

  1. patients with newly diagnosed prostate cancer have little concern for radiographic staging but rather focus on treatment, 2) physician trust imaging guidelines but are apt to follow their own intuition, fear medico-legal consequences, and succumb to influence from colleagues who image frequently. In spite of such discrepant views, most VHA physicians suggested or supported a large-scale effort to improve imaging use across VHA.

The investigators propose a multi-site, stepped wedge, cluster-randomized trial to determine the effect of a physician-focused behavioral intervention on VHA prostate cancer imaging use. The multi-level intervention, developed according to the Theoretical Determinants Framework, combines traditional physician behavior change methods with novel methods of communication and data collection. The intervention consists of three components: 1) a system of audit and feedback to clinicians informing individual clinicians and their sites about how their behavior compares to their peers' and to published guidelines 2) a program of academic detailing with the goal to educate providers about prostate cancer imaging, and 3) a CPRS Clinical Order Check for potentially inappropriate imaging. The intervention will be introduced to 10 participating geographically-distributed study sites.

The investigators will assess imaging rates 6 months prior to the intervention and 3 months following the intervention. The study's specific aims seek to understand the effects of the intervention on 1) facility-level prostate cancer imaging rates, 2) physician experience with and perceptions of the intervention and its implementation, and 3) the costs of both implementing the intervention and affecting change in imaging use. These aims will support a subsequent intervention to improve guideline-concordant imaging across VHA. Experience gained through this project will be leveraged to improve guideline-concordant care and increase operational effectiveness in other domains.

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The proposed behavioral intervention will be implemented according to a stepped wedge cluster-randomized design. This is a single direction cross-over randomized trial where every site serves, at some point, as both a control and an intervention site. The first time point will be a baseline measurement, where none of the study sites have yet received the intervention. At subsequent time points, study sites initiate the intervention. The time at which each site initiates implementation of the intervention is randomized.The proposed behavioral intervention will be implemented according to a stepped wedge cluster-randomized design. This is a single direction cross-over randomized trial where every site serves, at some point, as both a control and an intervention site. The first time point will be a baseline measurement, where none of the study sites have yet received the intervention. At subsequent time points, study sites initiate the intervention. The time at which each site initiates implementation of the intervention is randomized.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Actual Study Start Date :
Apr 9, 2018
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Feb 28, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

No intervention

Experimental: Intervention

The intervention is comprised of three components: 1) Clinical Order Check, 2) Academic Detailing, and 3) Audit and Feedback.

Behavioral: Clinical Order Check
A Clinical Order Check is an evidence-based, systems-level method to affect significant behavior change. It addresses the intervention functions of education, enablement and incentivization which are effective methods to change behaviors driven by beliefs about capabilities, knowledge, social influences, beliefs about consequences, and environmental context and resources. All VA facilities currently use locally adapted clinical reminders. This strategy is technologically simple, straightforward, and is considered to be a best practice within the VA IT community. The reminder will be self-explanatory and non-intrusive to workflow.

Behavioral: Academic Detailing
Academic detailing is an individual and facility-level intervention consistently shown to improve provider behavior. This strategy addresses the intervention functions of persuasion, coercion, modeling, and education which are effective methods for affecting behaviors driven by beliefs about capabilities, knowledge, social influences, beliefs about consequences, and environmental context and resources. During the meeting, the detailer will follow a script explaining that the visit is part of an experimental program to provide physicians with up-to-date, unbiased information about imaging to stage prostate cancer.

Behavioral: Audit and Feedback
Audit and feedback is an effective, individual-level intervention for changing healthcare provider behavior, resulting in small but potentially clinically important benefits. Audit and feedback addresses the intervention functions of education, persuasion and incentivization, all of which are important for addressing beliefs about capabilities and consequences, knowledge, and social influence.

Outcome Measures

Primary Outcome Measures

  1. Facility-level inappropriate prostate cancer imaging rates [Through study completion, an average of 4 years]

    Facility-level utilization of bone scan or abdominal/pelvic CT or abdominal/pelvic MRI among men with newly diagnosed, low-risk prostate cancer. (Inappropriate Imaging)

  2. Facility-level appropriate prostate cancer imaging rates [Through study completion, an average of 4 years]

    Facility-level utilization of bone scan or abdominal/pelvic CT or abdominal/pelvic MRI among men with newly diagnosed, high-risk prostate cancer. (Appropriate Imaging)

Secondary Outcome Measures

  1. Individual-level inappropriate prostate cancer imaging rates [Through study completion, an average of 4 years]

    Provider-level utilization of bone scan or abdominal/pelvic CT or abdominal/pelvic MRI among men with newly diagnosed, low-risk prostate cancer. (Inappropriate Imaging)

  2. Individual-level appropriate prostate cancer imaging rates [Through study completion, an average of 4 years]

    Provider-level utilization of bone scan or abdominal/pelvic CT or abdominal/pelvic MRI among men with newly diagnosed, high-risk prostate cancer. (Appropriate Imaging)

  3. Provider attitudes regarding prostate cancer imaging guidelines and the behavioral intervention [Through study completion, an average of 4 years]

    Qualitative outcome assessed through semi-structured, in-depth interviews with participating providers

  4. Net cost of implementation of the behavioral intervention [Through study completion, an average of 4 years]

    Budget impact analysis of intervention implementation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Provider Criteria:
  • Urology Chiefs and attending urologists employed through the VA (full time, part time) at one of the 10 participating sites

  • Physician Assistants and Nurse Practitioners employed through the VA at one of the 10 participating sites that work in the respective urology clinics

  • Providers may be any gender or race/ethnicity

Qualitative portion only:
  • Urology Chiefs and/or frontline staff physicians

  • participating PAs & NPs having cared for at least 5 men with incident prostate cancer within the previous 6 months

  • Patients will not be directly recruited into the study.

  • The investigators have obtained a waiver of HIPAA authorization and informed consent to analyze electronic health records of patients that are diagnosed with ICD-9 code 185 or ICD-10 code C61 during the study period at the 10 participating sites.

Exclusion Criteria:
Provider Criteria:
  • Urology Residents will be excluded.

Patients

  • Patients will be excluded if they have a history of prior malignancy

  • Are over the age of 85

  • Diagnosed at autopsy or by death certificate

  • Died within 3 months of diagnosis

  • Not having data on at least one of the following:

  • PSA

  • clinical stage

  • Gleason score

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California United States 94304-1290
2 VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles California United States 90073
3 VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven Connecticut United States 06516
4 Minneapolis VA Health Care System, Minneapolis, MN Minneapolis Minnesota United States 55417
5 Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY New York New York United States 10010
6 Syracuse VA Medical Center, Syracuse, NY Syracuse New York United States 13210
7 VA Portland Health Care System, Portland, OR Portland Oregon United States 97239
8 VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Pittsburgh Pennsylvania United States 15240
9 VA Salt Lake City Health Care System, Salt Lake City, UT Salt Lake City Utah United States 84148
10 VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington United States 98108
11 William S. Middleton Memorial Veterans Hospital, Madison, WI Madison Wisconsin United States 53705

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Danil V Makarov, MD MHS, Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT03445559
Other Study ID Numbers:
  • IIR 15-356
  • HX002038
First Posted:
Feb 26, 2018
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2022